Obamacare FAIL: The One Stock to Buy

Full disclosure, fellow investors: I'm as perplexed by the health insurance reform "conversation" as the next sentient citizen. Year in and year out, the cost of health care out-inflates all comers, and yet the beat goes on. And on and on and on ...

So too does the beating we all take in the form of higher insurance premiums. The math only gets uglier the farther out you look. The U.S. will spend trillions on health care this year, after all, and over the past 10 years, health-care costs have increased at four times the rate of inflation.

Four times!

Here's a shocker
Dyed-in-the-wool cheapskate that I am, I too have an overheated opinion about what should happen on the health-care front, but I'll spare you yet another one of those and cut to the chase. Plain and simple, the stock to buy if Obamacare looks destined to lose is UnitedHealth Group.

For my money, it's the insurance industry's best operator -- though, to be sure, it's struggled of late. The Minnesota-based concern has posted anemic earnings over the last three years, for example, even as its industry average rose at a double-digit clip. More bad news: UnitedHealth's debt profile goes the other way, with the company's debt/capital ratio surpassing the level of leverage sported by close competitors such as Aetna and WellPoint.

So what's UnitedHealth got that those companies don't?

Just this: A valuation profile that prices the company well below even a painstakingly conservative estimate of fair value. The company is cheaper than the broader market (as measured by the S&P 500), and it's trading at a healthy discount relative to peers in terms of price-to-cash flow, too.

About that cash flow ... UnitedHealth delivered roughly $3.5 billion of the stuff in fiscal 2008. And while that represented a sharp reduction relative to frothy fiscal years in 2006 and 2007, the company is on the comeback trail, posting almost $5.3 billion in FCF over last 12 months.

Industrial strength?
The upshot? If Obamacare fails -- which seems increasingly likely -- I suspect current purchases of UnitedHealth will turn out to be Foolishly wise investments in a great company in an industry poised to profit once the uncertainty discount currently afflicting health care fades -- and with it, perhaps, any chance of significant near-term cost controls. The market absolutely hates mystery, after all, a dynamic that can afflict even "safe haven" sectors like health care.

All of which leads to this question: Why not just bypass the uncertainty for now and go where the growth already is?

Relative to industry peers, for example, growth-oriented market leaders such as burrito concern Chipotle Mexican Grill (NYSE: CMG  ) and pharmaceutical giant Abbott Laboratories (NYSE: ABT  ) have delivered shoot-out-the-lights net-margin and return-on-equity figures over the last 12 turbulent months. So too have (Nasdaq: AMZN  ) and Gilead Sciences (Nasdaq: GILD  ) , another pair of go-go aces.

What's more, if analysts are even just directionally accurate, there's more growth where that came from. That fantastic four are all expected to increase earnings at a double-digit clip over the next five years.

Wall Street's rosy scenario spinners have similarly high hopes for the prospects of (Nasdaq: PCLN  ) , Agilent Technologies (NYSE: A  ) , and NetApp (Nasdaq: NTAP  ) , too.

Pay for the privilege
Priced at nearly 14 times its average cash flow over the last three years, NetApp is a clear illustration of the problem that I think afflicts all the above: There's not a bargain among 'em right now. Golden growth has been priced into their shares.

Not so much for UnitedHealth, though. It's a great company in a regulatory risky business that's currently trading for a proverbial song. If the legislative process evolves toward toothless reform -- complete with an expanded base of customers who are required to purchase health insurance, no less -- I suspect its stock price will shine.

The Foolish bottom line
One stock, of course, doesn't add up to Foolishly diversified sector exposure, but not to worry. While UnitedHealth is indeed a three-time recommendation of the Fool's Inside Value, the service has tapped nine other health-care concerns. Its current list of Best Buys Now, moreover, features one non-health care company trading at a discount of more than 45% to the team's conservative estimate of its intrinsic value.

A sneak peek at that company -- and every other recommendation the service has made, each of which comes with a recommended "buy below" price -- is completely free for the clicking. Just click right here to learn more.

Shannon Zimmerman runs point on the Fool's Duke Street and Ready Made Millionaire services, and he runs off at the mouth each week on Motley Fool Money, the Fool's fast n' furious radio show. Shannon doesn't own any of the stocks mentioned UnitedHealth Group is a Motley Fool Stock Advisor pick. The Fool owns shares of UnitedHealth Group. You can check out the Fool's strict disclosure policy right here.

Read/Post Comments (4) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 25, 2010, at 4:24 PM, asflkjdklasfjasf wrote:

    Oct 13, 2009 ... The Motley Fool - How to win if health-care reform fails.

    Dec 18, 2009 ... The Motley Fool - It's better to be prepared, right?

    I've noticed something about men who use the word "FAIL" as an interjection. For more information, sign up for my $89 newsletter.

  • Report this Comment On January 25, 2010, at 5:35 PM, chriscuster wrote:

    And, so, what is the ticker for this United Health Group? Why leave that info out?

  • Report this Comment On January 26, 2010, at 1:09 AM, asflkjdklasfjasf wrote:

    To find the ticker for this United Health Group, you'll have to sign up for the Fool's Inside Value. Just click here to start your 30-day FREE trial.

  • Report this Comment On January 26, 2010, at 8:50 PM, NoMulesFool wrote:


    UNH may be a great company but while you're singing its praises, it might be worth a mention that former CEO Doc McGuire, and Gov. Kean, and their cronies engaged in flagrant, criminal backdating, enriching themselves at the expense of shareholders. All the while, directors such as Walter "Fritz" Mondale, Donna Shalala, et al. turned a blind eye.


Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1092729, ~/Articles/ArticleHandler.aspx, 10/25/2016 10:38:36 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 hour ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 4:02 PM
A $43.51 Down -2.34 -5.10%
Agilent Technologi… CAPS Rating: ***
ABT $40.19 Down -0.22 -0.54%
Abbott Laboratorie… CAPS Rating: *****
AMZN $835.18 Down -2.91 -0.35% CAPS Rating: ****
CMG $405.67 Down -7.68 -1.86%
Chipotle Mexican G… CAPS Rating: ****
GILD $74.41 Up +0.26 +0.35%
Gilead Sciences CAPS Rating: *****
NTAP $34.00 Down -0.04 -0.12%
NetApp CAPS Rating: ****
PCLN $1479.03 Up +7.23 +0.49%
Priceline Group CAPS Rating: ****